215 related articles for article (PubMed ID: 36930284)
1. [Classification of Hodgkin lymphoma and related entities : News and open questions].
Hartmann S; Fend F
Pathologie (Heidelb); 2023 May; 44(3):184-192. PubMed ID: 36930284
[TBL] [Abstract][Full Text] [Related]
2. [Classification of peripheral T-cell lymphomas : News and open questions].
Fend F; Quintanilla-Martinez L; Klapper W
Pathologie (Heidelb); 2023 May; 44(3):173-183. PubMed ID: 37115288
[TBL] [Abstract][Full Text] [Related]
3. Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities.
Tousseyn TA; King RL; Fend F; Feldman AL; Brousset P; Jaffe ES
Virchows Arch; 2023 Jan; 482(1):207-226. PubMed ID: 36274093
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin Lymphoma and Its Differential Diagnosis: New Twists on an Old Challenge.
Sohani AR
Surg Pathol Clin; 2023 Jun; 16(2):287-346. PubMed ID: 37149361
[TBL] [Abstract][Full Text] [Related]
5. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis.
Churchill HR; Roncador G; Warnke RA; Natkunam Y
Hum Pathol; 2010 Dec; 41(12):1726-34. PubMed ID: 20825974
[TBL] [Abstract][Full Text] [Related]
6. A comparison and review of the flow cytometric findings in classic Hodgkin lymphoma, nodular lymphocyte predominant Hodgkin lymphoma, T cell/histiocyte rich large B cell lymphoma, and primary mediastinal large B cell lymphoma.
Martig DS; Fromm JR
Cytometry B Clin Cytom; 2022 Jan; 102(1):14-25. PubMed ID: 34878224
[TBL] [Abstract][Full Text] [Related]
7. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
[TBL] [Abstract][Full Text] [Related]
8. [Classification of aggressive B-cell lymphomas : News and open questions].
Rosenwald A; Menter T; Dirnhofer S
Pathologie (Heidelb); 2023 May; 44(3):166-172. PubMed ID: 36918411
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of STAT6
Van Slambrouck C; Huh J; Suh C; Song JY; Menon MP; Sohani AR; Duffield AS; Goldberg RC; Dama P; Kiyotani K; Godfrey J; Fitzpatrick C; Kline J; Smith SM; Jaffe ES; Hartmann S; Venkataraman G
Mod Pathol; 2020 May; 33(5):834-845. PubMed ID: 31822802
[TBL] [Abstract][Full Text] [Related]
10. Nodular lymphocyte predominant Hodgkin lymphoma: diagnostic pearls and pitfalls.
Smith LB
Arch Pathol Lab Med; 2010 Oct; 134(10):1434-9. PubMed ID: 20923296
[TBL] [Abstract][Full Text] [Related]
11. American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma.
O'Malley DP; Dogan A; Fedoriw Y; Medeiros LJ; Ok CY; Salama ME
Ann Diagn Pathol; 2019 Apr; 39():105-110. PubMed ID: 30802809
[TBL] [Abstract][Full Text] [Related]
12. [The 5th edition of the WHO classification of lymphoid neoplasms-an overview].
Kurz KS; Ott G
Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):64-70. PubMed ID: 36239779
[TBL] [Abstract][Full Text] [Related]
13. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
[TBL] [Abstract][Full Text] [Related]
14. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma.
Boudová L; Torlakovic E; Delabie J; Reimer P; Pfistner B; Wiedenmann S; Diehl V; Müller-Hermelink HK; Rüdiger T
Blood; 2003 Nov; 102(10):3753-8. PubMed ID: 12881319
[TBL] [Abstract][Full Text] [Related]
15. Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.
Jiang M; Bennani NN; Feldman AL
Expert Rev Hematol; 2017 Mar; 10(3):239-249. PubMed ID: 28133975
[TBL] [Abstract][Full Text] [Related]
16. Expression of c-FLIP in classic and nodular lymphocyte-predominant Hodgkin lymphoma.
Uherova P; Olson S; Thompson MA; Juskevicius R; Hamilton KS
Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):105-10. PubMed ID: 15354734
[TBL] [Abstract][Full Text] [Related]
17. [Update on nodular lymphocyte predominant Hodgkin's lymphoma and related lesions].
Hartmann S; Hansmann ML
Pathologe; 2017 Feb; 38(1):3-10. PubMed ID: 27999937
[TBL] [Abstract][Full Text] [Related]
18. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].
Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292
[TBL] [Abstract][Full Text] [Related]
19. Additional characterization of LEF1 expression in nodular lymphocyte predominant Hodgkin lymphoma and classic Hodgkin lymphoma.
Rea B; Bailey NG
Ann Diagn Pathol; 2021 Jun; 52():151730. PubMed ID: 33743303
[No Abstract] [Full Text] [Related]
20. The Hematological Differential Diagnosis of Mediastinal Masses.
Aljudi A; Weinzierl E; Elkhalifa M; Park S
Clin Lab Med; 2021 Sep; 41(3):389-404. PubMed ID: 34304771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
